Gaithersburg, MD, United States of America

John L Magnani

This inventor holds 48 USPTO granted patents and 43 published patent applications, plus 5 CIPO patents and 10 EPO patents, primarily in E-Selectin Antagonists. Top assignees: Glycomimetics, Inc., Glycotech Corp., Novartis Ag. Active years: 1999-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John L Magnani. Retrieved from https://idiyas.com/inventor/john-l-magnani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 48 (Patent Applications = 43)

% Patents Active = 87.5

CIPO Patents = 5 (Patent Applications = 15)

EPO Patents = 10 (Patent Applications = 36)

Average Co-Inventor Count = 2.2

ph-index = 19

Forward Citations = 624(Granted Patents)

Location History:

Frederick, MD (US) (2002)
Rockville, MD (US) (1999 - 2004)
Gaithersburg, MD (US) (2002 - 2024)

Company Filing History:

The General Hospital Corporation

patents

5. 6 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2024

Loading Chart...

Areas of Expertise:

E-Selectin

Galectin-3

Glycomimetics

Heterobifunctional Inhibitors

Cancer Treatment

Cardiovascular Disease

T-Cell Checkpoint Inhibitors

Marrow Infiltrating Lymphocytes

Pan-Selectin Inhibitors

Sickle Cell Disease

Prostate Cancer

Multivalent Polymers

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11987598 - E-selectin antagonist compounds, compositions, and methods of use (2024-05-21),

2. 11878026 - Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists (2024-01-23),

3. 11873317 - Galectin-3 inhibiting c-glycosides (2024-01-16),

4. 11845771 - Heterobifunctional inhibitors of E-selectin and galectin-3 (2023-12-19),

5. 11780873 - Highly potent multimeric e-selectin antagonists (2023-10-10),

6. 11712446 - Methods of mobilizing marrow infiltrating lymphocytes and uses thereof (2023-08-01),

7. 11548908 - Heterobifunctional inhibitors of E-selectin and galectin-3 (2023-01-10),

8. 11433086 - Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4 (2022-09-06),

9. 11332491 - E-selectin antagonist compounds, compositions, and methods of use (2022-05-17),

10. 11291678 - Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin (2022-04-05),

11. 11197877 - Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists (2021-12-14),

12. 11072625 - Highly potent multimeric e-selectin antagonists (2021-07-27),

13. 11045485 - Glycomimetic inhibitors of PA-IL and PA-IIL lectins (2021-06-29),

14. 10766916 - E-selectin antagonist compounds, compositions, and methods of use (2020-09-08),

15. 10526361 - E-selectin antagonist compounds, compositions, and methods of use (2020-01-07),

Title: The Innovative Journey of John L. Magnani

Introduction:

John L. Magnani, a talented inventor based in Gaithersburg, MD, has made significant contributions to the field of technology and innovation. His passion for creating groundbreaking solutions has led to numerous patents and collaborations throughout his career.

Latest Patents:

John L. Magnani's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and medical devices. His innovative approach to problem-solving is evident in each of his patented inventions.

Career Highlights:

With a background in engineering and a keen eye for detail, John L. Magnani has established himself as a pioneer in the industry. His career highlights include developing a revolutionary software platform for data analysis and receiving multiple awards for his contributions to the field.

Collaborations:

John L. Magnani has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has resulted in successful partnerships and groundbreaking innovations.

Conclusion:

In conclusion, John L. Magnani's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His impact on the world of technology continues to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.